Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot symbols : Sonn save search
Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors
Published: 2022-03-16 (Crawled : 12:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 79.48%
H: 35.23%
C: 4.04%
son-1010 treatment fda clearance solid tumors therapeutics fda clearance iot
Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
Published: 2022-02-08 (Crawled : 12:30) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -5.76%
therapeutics iot
Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update
Published: 2021-12-17 (Crawled : 14:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: -6.34%
H: 0.0%
C: 0.0%
therapeutics iot
Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update
Published: 2021-08-16 (Crawled : 11:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: -11.32%
iot
Sonnet BioTherapeutics Announces Change in Date of Annual Meeting
Published: 2021-06-14 (Crawled : 12:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 2.47%
H: 0.23%
C: -3.61%
iot
Sonnet BioTherapeutics Announces Issuance of U.S. Patent for Platform Technology
Published: 2021-06-08 (Crawled : 00:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 1.99%
H: 1.29%
C: -0.65%
patent technology iot platform
Sonnet BioTherapeutics Provides Fiscal Year 2021 Second Quarter Business and Earnings Update
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: -4.43%
H: 11.92%
C: 8.61%
iot
Sonnet BioTherapeutics Completes Successful GLP Repeat Dose Toxicology Study of IL12-FHAB (SON-1010) in Non-Human Primates (NHP)
Published: 2021-05-10 (Crawled : 12:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 2.47%
H: 0.6%
C: -4.82%
iot
Sonnet BioTherapeutics Completes Licensing Agreement with New Life Therapeutics
Published: 2021-05-03 (Crawled : 11:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 9.28%
H: 5.41%
C: -20.08%
iot license therapeutics
Sonnet BioTherapeutics Appoints Richard Kenney as Chief Medical Officer and Manuel Dafonseca as Head of Clinical Operations
Published: 2021-03-22 (Crawled : 12:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 0.39%
H: 1.56%
C: -2.33%
iot
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.